Search concepts
|
Selected Filters
|
- 100 - 125 out of 139 results
Search results
-
Federal Funding Agencies
Role of B-lactamase encoding gene amplification in the development of non-carbapenemase producing, carbapenem-resistant Enterobacteriaceae
3/1/22 → 2/29/24
Project: Federal Funding Agencies
-
Modulating B and T cell functions in EAE through gamma secretase and Notch
Natl Inst of Neuro Disorders and Stroke
8/1/13 → 5/31/18
Project: Federal Funding Agencies
-
Intranasal Delivery of Telomerase Reverse Transcriptase mRNA for Therapy of Traumatic Brain Injury
9/26/22 → 8/31/24
Project: Federal Funding Agencies
-
SUPRASPINAL TARGETS IN NEUROGENIC VOIDING DYSFUNCTION
Khavari, R., Boone, T. B., Helekar, S. & Karmonik, C.
8/17/18 → 7/31/22
Project: Federal Funding Agencies
-
Exosome analysis of drug-resistant cancer cells response to nanoparticle therapy
12/1/15 → 11/30/18
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
6/1/19 → 4/30/24
Project: Federal Funding Agencies
-
High Density Lipoprotein Biogenesis and Speciation
Pownall, H. J., Rosales, C. & Gillard, B. K.
National Heart Lung and Blood Institute
8/1/16 → 5/31/21
Project: Federal Funding Agencies
-
Ciliary Micropillar Enriched Exosomal microRNA for Cancer Diagnosis by Multiplexed Photonic Crystal Sensor
9/22/15 → 6/21/16
Project: Federal Funding Agencies
-
-
The Germ Cell Gene TDRD1 as a Novel Prostate Cancer Biomarker
3/15/17 → 8/31/23
Project: Federal Funding Agencies
-
Understanding of Central Neural Activity and Regional Connectivity Involved in Neurogenic Bladder Dysfunction During Micturition Cycle.
12/1/14 → 7/31/18
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
9/30/19 → 5/31/24
Project: Federal Funding Agencies
-
Evaluation of immune responses to CD44-targeted nanovectors for designing a novel anti-tuberculosis host-directed therapy
Godin, B., Jagannath, C. & Leonard, F.
5/1/20 → 10/31/22
Project: Federal Funding Agencies
-
Targeting ER stress response in B-cell chronic lymphocytic leukemia
Hu, C. A., Pingali, S. R. & Tang, C. A.
4/1/21 → 3/31/25
Project: Federal Funding Agencies
-
Non Profit
Eradication of Advanced Prostate Cancer by Chimeric Antigen Receptor-T Cell Therapy with A Safety Switch
1/1/24 → 12/31/25
Project: Non Profit
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
Logic-Embedded Nanovectors for Stroma Remodeling and siRNA Delivery to Breast Tumors
10/31/12 → 12/20/13
Project: Non Profit
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix B - For verdiperstat (also known as BHV-3241)
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T., Butler, E. B., Darcourt, J., Farach, A. M., Kamat, A. A., Shkedy, C., Singh, M. & Suri, A.
3/1/14 → 2/28/39
Project: Non Profit
-
Synchrony: Holistic Program for Veterans
Madan, A., Fowler, C. & Weinstein, B.
7/1/20 → 6/30/21
Project: Non Profit
-
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix A - For 0.3mh/kg SC zilucoplan administered once daily and placebo
Appel, S. H., Shroff, S., Greene, E. P., Liao, B. & Thonhoff, J. R.
7/24/20 → 7/23/25
Project: Non Profit